Ameliorating post-infarction myocardial fibrosis and cardiac function via ROS-responsive hydrogel-mediated IL-11 antibody delivery
Myocardial fibrosis, driven by fibroblast activation following myocardial infarction (MI), represents a significant pathological process contributing to heart failure progression. Interleukin-11 (IL-11) is recognized as a key mediator in fibrotic pathologies across multiple organs, including the hea...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
KeAi Communications Co., Ltd.
2026-06-01
|
| סדרה: | Bioactive Materials |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2452199X26000423 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
